The Accuracy of Medicare Claims as an Epidemiological Tool: The Case of Dementia Revisited
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Our study estimates the sensitivity and specificity of Medicare claims to identify clinically-diagnosed dementia, and documents how errors in dementia assessment affect dementia cost estimates. We compared Medicare claims from 1993-2005 to clinical dementia assessments carried out in 2001-2003 for the Aging Demographics and Memory Study (ADAMS) cohort (n = 758) of the Health and Retirement Study. The sensitivity and specificity of Medicare claims was 0.85 and 0.89 for dementia (0.64 and 0.95 for AD). Persons with dementia cost the Medicare program (in 2003) $7,135 more than controls (P < 0.001) when using claims to identify dementia, compared to $5,684 more when using ADAMS (P < 0.001). Using Medicare claims to identify dementia results in a 110% increase in costs for those with dementia as compared to a 68% increase when using ADAMS to identify disease, net of other variables. Persons with false positive Medicare claims notations of dementia were the most expensive group of subjects ($11,294 versus $4,065, for true negatives P < 0.001). Medicare claims overcount the true prevalence of dementia, but there are both false positive and negative assessments of disease. The use of Medicare claims to identify dementia results in an overstatement of the increase in Medicare costs that are due to dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“But outside of research settings, a substantial portion of those who would meet the diagnostic criteria for Alzheimer's and other dementias are not diagnosed with dementia by a physician.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [253]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“patients with pre-hospitalization diagnosis of dementia were identified using a validated algorithm developed by Taylor and colleagues (ICD-9 codes 331.0, 331.1, 331.2, 331.7, 290.0, 290.1, 290.10, 290.11, 290.12, 290.13, 290.20, 290.21, 290.3, 290.40, 290.41, 290.42, 290.43, 294.0, 294.1, 294.8, and 797).39”
From Discharge Communication of Dementia-Related Neuropsychiatric Symptoms and Care Management Strategies during Hospital to Skilled Nursing Facility Transitions (2021) · cites this paper as [39]
The cited source says what the claim attributes to it.
In the citing paper
“For example, the positive predictive value of a dementia claim in U.S. Medicare claims is only 56% (Taylor et al. 2009).”
From Exposure to Air Pollution in Relation to Risk of Dementia and Related Outcomes: An Updated Systematic Review of the Epidemiological Literature (2021) · cites this paper as Taylor et al. 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148 · cited 2×
“We also compared the agreement of ADAMS and Medicare claims diagnoses by calculating the kappa statistic to estimate agreement between ADAMS and Medicare claims [29].”
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332 · cited 1×
“The increasing number of persons diagnosed with dementia is a defining demographic fact of American society that will have a profound impact on both families and the formal health care system [1].”
The quality of health care delivered to adults in the United States
McGlynn, E. A., Asch, S. M., Adams, J., Keesey, J., Hicks, J., DeCristofaro, A., & Kerr, E. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmsa022615 · Cited by 5,079
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168
Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., et al. (2007) · Neuroepidemiology · doi:10.1159/000109998 · Cited by 1,932 · cited 5×
“However, this level of education is not unusual for this sample and education was not found to be a multivariate predictor of agreement, though education has been found to be a significant predictor of dementia in past work using ADAMS [7].”
InfluentialSelf-citationBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787 · cited 1×
“A series of dementia prevalence estimates have been reported over time [3–6], each using different study samples and methods of disease identification.”
Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
Prevalence of Cognitive Impairment without Dementia in the United States
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-6-200803180-00005 · Cited by 929 · cited 3×
“All persons classified as having CIND at the initial assessment received a follow up assessment [28].”
Self-citationThe accuracy of Medicare's hospital claims data: progress has been made, but problems remain.
Fisher, E. S., Whaley, F. S., Krushat, W. M., Malenka, D. J., Fleming, C., Baron, J. A., & Hsia, D. C. (1992) · American Journal of Public Health · doi:10.2105/ajph.82.2.243 · Cited by 709 · cited 2×
“Previous research has shown modest sensitivity of claims to detect dementia diagnosed by other means [17–19], and past sensitivity estimates of claims to detect dementia (80% in one study) [20]may not hold in a broader sample because a non-clinical study population would be expected to have a…”
InfluentialMedicare Beneficiaries’ Costs Of Care In The Last Year Of Life
Hogan, C., Lunney, J., Gabel, J., & Lynn, J. (2001) · Health Affairs · doi:10.1377/hlthaff.20.4.188 · Cited by 544
The Aging, Demographics, and Memory Study: Study Design and Methods
Langa, K. M., Plassman, B. L., Wallace, R. B., Herzog, A. R., Heeringa, S. G., Ofstedal, M. B., Burke, J. R., Fisher, G. G., Fultz, N. H., Hurd, M. D., et al. (2005) · Neuroepidemiology · doi:10.1159/000087448 · Cited by 413 · cited 5×
“Such an approach is the best way to obtain reliable estimates of the prevalence of dementia, but is expensive [8].”
InfluentialSelf-citationBynum, J. P. W., Rabins, P. V., Weller, W., Niefeld, M., Anderson, G. F., & Wu, A. W. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52054.x · Cited by 405
Estimated Prevalence of Alzheimer's Disease in the United States
Evans, D. A. (1990) · The Milbank Quarterly · doi:10.2307/3350099 · Cited by 357
Taylor, D. H., Whellan, D. J., & Sloan, F. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400408 · Cited by 289
The accuracy of medicare claims data in identifying Alzheimer's disease
Taylor, D. H., Fillenbaum, G. G., & Ezell, M. E. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00452-3 · Cited by 258 · cited 3×
“…sensitivity of claims to detect dementia diagnosed by other means [17–19], and past sensitivity estimates of claims to detect dementia (80% in one study) [20]may not hold in a broader sample because a non-clinical study population would be expected to have a broader range of disease severity.”
InfluentialWhite, L. R., Katzman, R., Losonczy, K. G., Salive, M. E., Wallace, R. B., Berkman, L. F., Taylor, J. O., Fillenbaum, G. G., & Havlik, R. J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90157-0 · Cited by 170 · cited 1×
“Educational attainment can also make determination of dementia status more difficult [27,28, 32] but might be expected to lead to false positives, not false negatives.”
Self-citationNewcomer, R., Clay, T., Luxenberg, J. S., & Miller, R. H. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb04580.x · Cited by 125 · cited 2×
“Errors associated with using Medicare claims records (undercounting clinically diagnosed disease) have been found to lead to overstating the cost increase to the Medicare program associated with having dementia [18].”
Treatment for Breast Cancer in Patients with Alzheimer's Disease
Gorin, S. S., Heck, J. E., Albert, S., & Hershman, D. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.00467.x · Cited by 109 · cited 1×
“When analysts use Medicare claims records to identify dementia, they are often interested in the effect of dementia on the cost to the Medicare program [10– 12 , 18 ].”
Increasing Rates of Dementia at Time of Declining Mortality From Stroke
Ukraintseva, S., Sloan, F., Arbeev, K., & Yashin, A. (2006) · Stroke · doi:10.1161/01.str.0000217971.88034.e9 · Cited by 104 · cited 1×
“Medicare claims records have been used in past research to identify the cost and outcome of care financed by the program for patients with specific conditions [8, 9], including AD and other dementias [11–14], as well as to identify trends in diagnosed prevalence of dementia [15,16].”
How Much Do Persons with Alzheimer's Disease Cost Medicare?
Taylor, D. H., & Sloan, F. A. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04721.x · Cited by 99 · cited 3×
“Cost to the Medicare program was defined as the amount that Medicare actually paid for an episode of care and using all files as noted above, following past work in this area [9,11,12].”
Weiner, M., Powe, N. R., Weller, W. E., Shaffer, T. J., & Anderson, G. F. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb03814.x · Cited by 97 · cited 2×
“This study uses the ICD-9-CM codes used in past work to identify dementia in Medicare claims (Appendix 1) [19].”
Cost of Illness of Alzheimer's Disease: How Useful Are Current Estimates?
Bloom, B. S., de Pouvourville, N., & Straus, W. L. (2003) · The Gerontologist · doi:10.1093/geront/43.2.158 · Cited by 93 · cited 2×
“Further, an obvious use of claims-based dementia diagnoses is to determine the effect of dementia on Medicare costs, a key policy question on which there is no consensus [2].”
Treatment of Dementia in Community‐Dwelling and Institutionalized Medicare Beneficiaries
Gruber‐Baldini, A. L., Stuart, B., Zuckerman, I. H., Simoni‐Wastila, L., & Miller, R. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01387.x · Cited by 77
Plassman, B. L., Khachaturian, A. S., Townsend, J. J., Ball, M. J., Steffens, D. C., Leslie, C. E., Tschanz, J. T., Norton, M. C., Burke, J. R., Welsh‐Bohmer, K. A., et al. (2006) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.11.001 · Cited by 47
Self-citationEffect of Alzheimer Disease on the Cost of Treating Other Diseases
Sloan, F. A., & Taylor, D. H. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200207000-00002 · Cited by 47 · cited 2×
“When analysts use Medicare claims records to identify dementia, they are often interested in the effect of dementia on the cost to the Medicare program [10– 12 , 18 ].”
Marked Increase in Alzheimer's Disease Identified in Medicare Claims Records Between 1991 and 1999
Taylor, D. H., Sloan, F. A., & Murali Doraiswamy, P. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.7.m762 · Cited by 46
Research works printed but not linked: 3
- [6]United States General Accounting Office. Alzheimer’s Disease: Estimates of Prevalence in the United States. Washington: United States General Accounting Office; 1998. [Google Scholar]
- [21]American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3. Washington, D.C: American Psychiatric Association; 1987. Revised. [Google Scholar]
- [22]American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4. Washington, DC: American Psychiatric Association; 1994. [Google Scholar]
Cited by
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
2024 Alzheimer's disease facts and figures
(2024) · Alzheimer's & Dementia · doi:10.1002/alz.13809 · Cited by 2,536
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
Metadata
- Authors
- Taylor, Jr., Østbye, T., Langa, K. M., Weir, D., & Plassman, B. L.
- Affiliations
- Center for Health Policy, Sanford Duke School of Public Policy, Duke University, Durham, NC, USA
- Duke Medical Center (US)
- University of Michigan (US)
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2009-07-23
- Volume
- 17
- Issue
- 4
- Pages
- 807-815
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC3697480
- OpenAlex
- W1934443959
- Cited by
- 354
- References
- 29
- Citations by year
- 2026: 24 · 2025: 42 · 2024: 30 · 2023: 26 · 2022: 44 · 2021: 38 · 2020: 27 · 2019: 22 · 2018: 23 · 2017: 19 · 2016: 22 · 2015: 14 · 2014: 7 · 2013: 3 · 2012: 7
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (U01 AG 09740, U01AG009740, R01AG027010)
- National Institute of Nursing Research (R01NR008763)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Health Professions › Health Information Management › Medical Coding and Health Information
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- Medicare claims data, dementia
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Dementia, Female, Medicare, Humans, Insurance Claim Reporting, Male, Sensitivity and Specificity, United States, Cohort Studies, Prevalence, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.